These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 12225246)
1. Therapeutic potential of GnRH antagonists in the treatment of precocious puberty. Roth C Expert Opin Investig Drugs; 2002 Sep; 11(9):1253-9. PubMed ID: 12225246 [TBL] [Abstract][Full Text] [Related]
2. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine. Roth CL; Brendel L; Rückert C; Hartmann K Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342 [TBL] [Abstract][Full Text] [Related]
3. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models. Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254 [TBL] [Abstract][Full Text] [Related]
4. New developments in the use of peptide gonadotropin-releasing hormone antagonists versus agonists. Schultze-Mosgau A; Griesinger G; Altgassen C; von Otte S; Hornung D; Diedrich K Expert Opin Investig Drugs; 2005 Sep; 14(9):1085-97. PubMed ID: 16144493 [TBL] [Abstract][Full Text] [Related]
5. GnRH antagonist cetrorelix prevents sexual maturation of peripubertal male rats. Roth C; Leonhardt S; Seidel C; Lakomek M; Wuttke W; Jarry H Exp Clin Endocrinol Diabetes; 2000; 108(5):358-63. PubMed ID: 10989955 [TBL] [Abstract][Full Text] [Related]
6. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty. Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629 [TBL] [Abstract][Full Text] [Related]
7. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Yen SS Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group. Sippell WG Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698 [TBL] [Abstract][Full Text] [Related]
9. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152 [TBL] [Abstract][Full Text] [Related]
10. A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls. Brito VN; Latronico AC; Arnhold IJ; Mendonca BB J Clin Endocrinol Metab; 2004 Sep; 89(9):4338-42. PubMed ID: 15356030 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model. Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237 [TBL] [Abstract][Full Text] [Related]
12. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate). Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897 [TBL] [Abstract][Full Text] [Related]